Tuesday's Health Winners & Losers - TheStreet

Tuesday's Health Winners & Losers

Teva runs higher.
Author:
Publish date:

Shares of

Teva Pharmaceutical

(TEVA) - Get Report

were rising after the generic-drug maker posted fourth-quarter earnings that jumped 51% from the previous year. Teva was higher by $1.96, or 5.5%, to $37.32.

Late Monday,

Cephalon

(CEPH)

said it swung to a fourth-quarter loss of $4.9 million, or 8 cents a share. Excluding charges, the company earned $1.06 a share, handily beating estimates. Cephalon, which also upped its full-year forecast, was recently gaining $3.25, or 4.5%, to $75.70.

Sanofi-Aventis

(SNY) - Get Report

posted a fourth-quarter profit that slipped 4.6% from the year-ago quarter, hurt by generic alternatives to its blood-thinning drug Plavix. The stock was losing $1.14, or 2.6%, to $43.15.

Momenta Pharmaceuticals

(MNTA) - Get Report

fell 3.1% after the company posted a fourth-quarter loss that swelled from a year ago. Momenta was recently down 47 cents to $14.50.

Among health care stocks gaining ground,

Onyx Pharmaceuticals

(ONXX)

was rising 7.3% to $25.92;

Illumina

(ILMN) - Get Report

was gaining 4.6% to $36.55; and

King Pharmaceuticals

(KG)

was adding 2.2% to $18.41.

As for decliners,

Celgene

(CELG) - Get Report

fell 2.1% to $53.15;

MedImmune

(MEDI)

was losing 1.9% to $31.14; and

Forest Labs

(FRX)

was off 1.6% to $53.25.